David J. Osborne

1.4k citations
38 papers · 1.1k indexed · h-index 19
Topics
Eicosanoids and Hypertension Pharmacology (6 papers)Inflammatory mediators and NSAID effects (6 papers)Asthma and respiratory diseases (6 papers)

In The Last Decade

David J. Osborne

36 papers receiving 1.0k citations

Peers

David J. Osborne
Comparison fields: 5 of 110
  • Molecular Biology 331
  • Pharmacology 260
  • Cell Biology 199
  • Cellular and Molecular Neuroscience 187
  • Physiology 176
Replace J. Damas with:
J. Damas Belgium
Yuling Chi United States
Hong Nie China
Kyohei Higashi Japan
Georges Némoz France
Nikos Sakellaridis Greece
Shin‐Young Park South Korea
Valeria Sogos Italy
Yifei Dong Canada
Nitish R. Mahapatra India
David J. Osborne relative to J. Damas Belgium J. Damas's profile →
Citations per field
00.5×5.4×
J. Damas · 1×
Citations per year

Countries citing papers authored by David J. Osborne

Since Specialization
Citations

This map shows the geographic impact of David J. Osborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Osborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Osborne more than expected).

Fields of papers citing papers by David J. Osborne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Osborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Osborne. The network helps show where David J. Osborne may publish in the future.

Co-authorship network of co-authors of David J. Osborne

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Osborne. A scholar is included among the top collaborators of David J. Osborne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Osborne. David J. Osborne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 47
2 80
3 40
4 172
5 38
6 9
7 14
8 13
9 18
10 29
11 37
12 7
13 19
14 30
15 18
16 1
17 28
18 3
19 6
20 163

About David J. Osborne

David J. Osborne is a scholar working on Biochemistry, Molecular Medicine and Equine, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Asthma and respiratory diseases (6 papers). The work is most often cited by research in Biochemistry (124 citations), Pharmacology (260 citations) and Molecular Medicine (63 citations). David J. Osborne has collaborated with scholars based in United Kingdom, United States and Nepal. Frequent co-authors include Anthony F. Cockerill, David N. B. Mallen, Catherine M. Davidson, Michael T. Bayliss, W Dawson, Stephen Carney, J.R. Boot, Mark Ward, John R. Stanley and Michael J. O’Neill. Their work appears in journals such as Nature, Journal of Biological Chemistry and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026